参考文献/References:
[1] 国家卫生计生委脑卒中防治工程委员会.中国脑卒中防治指导规范(2021年版)[EB/OL].2022, www.nhc.gov.cn/yzygj/s3593/202108/50c4071a86df4bfd9666e9ac2aaac605.shtml.
[2] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志,2019,52(4):1006-7876.
[3] Wu SM, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405.
[4] Feske SK. Ischemic stroke[J]. Am J Med, 2021, 134(12): 1457-1464.
[5] Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications[J]. Med Res Rev, 2022, 42(1): 259-305.
[6] 吴典.生存素在新生儿缺氧性肺动脉高压肺血管重塑中的作用机制研究进展[J].国际儿科学杂志,2020,47(6):407-410.
[7] 朱晓梦,安光祖,李铭明,等.过表达生存素对颅脑外伤大鼠神经细胞凋亡和神经功能的影响[J].中华实验外科杂志,2021,38(7):1287-1290.
[8] Azemin WA, Alias N, Ali AM, et al. Structural and functional characterisation of HepTH1-5 peptide as a potential hepcidin replacement[J]. J Biomol Struct Dyn, 2021, 6(2021): 1-24.
[9] Zhang X, Gou YJ, Zhang Y, et al. Hepcidin overexpression in astrocytes alters brain Iron metabolism and protects against amyloid-β induced brain damage in mice[J]. Cell Death Discov, 2020, 6(1): 113.
[10] Adams HJ, Bendixen BH, Kappelle LJ, et al. Definitions for use in a multicenter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1): 35-41.
[11] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):1006-7876.
[12] 张磊,刘建民.改良Rankin量表[J].中华神经外科杂志,2012,28(5):512.
[13] 国家神经系统疾病医疗质量控制中心.中国卒中学会.急性缺血性卒中再灌注治疗医疗质量评价与改进专家建议[J].中国卒中杂志,2021,16(7):1673-5765.
[14] Berge E, Whiteley W, Audebert H, et al. European stroke organisation(ESO)guidelines on intravenous thrombolysis for acute ischaemic stroke[J]. Eur Stroke J, 2021, 6(1): I-LXII.
[15] Mccullough LD, Roy-O'reilly M, Lai YJ, et al. Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice[J]. J Clin Invest, 2021, 131(17): e144898.
[16] Guzmán EA, Pitts TP, Tandberg KR, et al. Discovery of survivin inhibitors part 1: screening the harbor branch pure compound library[J]. Mar Drugs, 2021, 19(2): 73.
[17] Li Y, Lu W, Yang J, et al. Survivin as a biological biomarker for diagnosis and therapy[J]. Expert Opin Biol Ther, 2021, 21(11): 1429-1441.
[18] Sun JD, Li XM, Liu JL, et al. Effects of miR-150-5p on cerebral infarction rats by regulating the Wnt signaling pathway via p53[J]. Eur Rev Med Pharmacol Sci, 2020, 24(7): 3882-3891.
[19] Zhan L, Liu D, Wen H, et al. Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation[J]. FASEB J, 2019, 33(8): 9291-9307.
[20] 王立一,王子豪,范照鑫,等.铁代谢在创伤性颅脑损伤中的研究进展[J].中国微侵袭神经外科杂志,2021,26(3):133-136.
[21] Yao MY, Liu T, Zhang L, et al. Role of ferroptosis in neurological diseases[J]. Neurosci Lett, 2021, 747(2021): 135614.
[22] Zhao Y, Xin Z, Li N, et al. Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating Iron metabolism[J]. Free Radic Biol Med, 2018, 124(2018): 1-11.
[23] Wang P, Cui Y, Ren Q, et al. Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibiting ferroptosis[J]. Cell Death Dis, 2021, 12(5): 447.
[24] 朱蕊,曾庆,黄国志,等.铁死亡与脑卒中[J].中国组织工程研究,2021,25(23):3734-3739.
[25] Zhang Y, Lu X, Tai B, et al. Ferroptosis and its multifaceted roles in cerebral stroke[J]. Front Cell Neurosci, 2021, 15(2021): 615372.
相似文献/References:
[1]白文婷,杨丽荣,吕利英,等.多个危险因素聚集与急性缺血性脑卒中患者出院结局不良的关系[J].卒中与神经疾病杂志,2015,22(02):71.
[2]陈翠荣,赵振国,周媛,等.轻中度急性脑梗死MRI指导下超时间窗静脉溶栓治疗的研究[J].卒中与神经疾病杂志,2014,21(06):330.
[3]但毕堂,彭小祥,陈小奇,等.急性缺血性脑卒中时间窗内的动静脉溶栓分层治疗的对比研究[J].卒中与神经疾病杂志,2014,21(06):334.
[4]宗彦武,蔡柳燕,张岩.神经介入联合阿加曲班对急性缺血性脑卒中患者血清FIB,D-D表达水平的影响[J].卒中与神经疾病杂志,2022,29(04):365.[doi:10.3969/j.issn.1007-0478.2022.04.012]
[5]秦雅鑫 任占云 李杰 许冬华 叶沈早 陈蒋楠.Willis环完整性和脑白质变化对急性缺血性脑卒中患者神经功能缺损及预后的影响[J].卒中与神经疾病杂志,2023,30(03):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
Qin Yaxin,Ren Zhanyun,Li Jie,et al.Effects of Willis ring integrity and white matter changes on neurological deficit and prognosis in patients with acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(05):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
[6]顾亮亮 王建锋 乔鑫 张保朝 傅国惠.急性缺血性脑卒中患者静脉溶栓前后SCUBE1水平的变化及其与预后不良的相关性分析[J].卒中与神经疾病杂志,2023,30(03):265.[doi:10.3969/j.issn.1007-0478.2023.03.006]
Gu Liangliang*,Wang Jianfeng,Qiao Xin*,et al.Changes of SCUBE1 levels after thrombolytic therapy in patients with acute ischemic stroke and its correlation with prognosis[J].Stroke and Nervous Diseases,2023,30(05):265.[doi:10.3969/j.issn.1007-0478.2023.03.006]
[7]孙光文 徐仕皓 王媛媛 毛瑞 杨文琼.PTX3联合LP-PLA2水平与急性缺血性脑卒中合并颈动脉狭窄的关系[J].卒中与神经疾病杂志,2023,30(03):273.[doi:10.3969/j.issn.1007-0478.2023.03.008]
Sun Guangwen*,Xu Shihao,Wang Ruanruan,et al.Correlation analysis of PTX3 combined with LP-PLA2 in carotid stenosis in acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(05):273.[doi:10.3969/j.issn.1007-0478.2023.03.008]
[8]龚汉贤,庄泽微,李述桃,等.球囊导引导管在老年急性缺血性脑卒中患者取栓治疗中的作用[J].卒中与神经疾病杂志,2024,31(01):73.[doi:10.3969/j.issn.1007-0478.2024.01.012]